Volume 4, Issue 1 , Pages 29-35, January 2006
Hepatocellular Carcinoma: Patients With Increasing Alpha-Fetoprotein But No Mass on Ultrasound
A 63-year-old man with hepatitis C virus–induced cirrhosis is referred to the clinic for evaluation of an increase in the level of alpha-fetoprotein (AFP) to 400 ng/mL, which was detected in a blood test performed by the primary care physician. The patient is active at work and asymptomatic. He has compensated cirrhosis and well-preserved liver function, with a serum albumin level of 38 g/L, a serum bilirubin level of 1.6 mg/dL, and a prothrombin time of 1.2 international normalized ratio. Physical examination shows a liver span of 4 cm and splenomegaly without ascites. The ultrasound examination shows hepatomegaly without any liver mass, preserved portal blood flow, and splenomegaly.
Abbreviations used in this paper: AFP, alpha-fetoprotein , AFP-L3, lens culinaris agglutinin-reactive AFP , CT, computed tomography , EASL, European Association for the Study of Liver Diseases , HBV, hepatitis B virus , HCC, hepatocellular carcinoma , HCV, hepatitis C virus , MRI, magnetic resonance imaging , US, ultrasonography
J. M. Llovet, Professor of Research–Institut Catala de Recerca Avançada (ICREA), is supported by the ICREA and the Instituto de Salud Carlos III (Fondo de Investigaciones Sanitarias 2002–2005, PI02/0596).
PII: S1542-3565(05)00864-5
© 2006 American Gastroenterological Association. Published by Elsevier Inc. All rights reserved.
Volume 4, Issue 1 , Pages 29-35, January 2006


